Today: 15.Dec.2018

Ludwig Feinendegen, M.D., former director of the Department of Nuclear Medicine, University Hospital, Heinrich Heine University Duesseldorf, Germany, 2010 Marie Curie Prize - Jerry Cuttler, D.Sc. in nuclear sciences and engineering, recipient of 2011 International Dose-Response Society Award for Outstanding Career Achievement: There is considerable controversy regarding risk of health detriment after low-level exposure to ionizing radiation. This stems in part from a sort of distance between radiation biologists, epidemiologists, and radiation protection professionals, as well as regulatory institutions. This feeds seriously into a somewhat hazy fear of ionizing radiation that besets large portions of the public.

Published in Low Dose Radiation

Nicholas Dainiak, Ludwig Feinendegen, Randall Hyer, Paul Locke, Alan Waltar: Today is the time for acknowledgement of new models for biological response to low dose and low dose rate radiation on biological processes and human disease. The new deadline for submitting Abstracts is March 1, 2018. Submit Abstract at this website: http://www.lowdoserad.org/ For additional information contact Dr. Alan Waltar, conference chair at This email address is being protected from spambots. You need JavaScript enabled to view it., or Dr. Tony Brooks, technical program co-chair at This email address is being protected from spambots. You need JavaScript enabled to view it..

Published in Low Dose Radiation

Ludwig Feinendegen, M.D., former director of the Department of Nuclear Medicine, University Hospital, Heinrich Heine University Duesseldorf, Germany, 2010 Marie Curie Prize - Jerry Cuttler, D.Sc. in nuclear sciences and engineering, recipient of 2011 International Dose-Response Society Award for Outstanding Career Achievement: This is a summary statement about low dose radiation from all the articles by these scientist posted on efn-usa.org. "By far, the dominant risk of cancer is from the oxidation effects of oxygen we breath, not low dose radiation."

Published in Low Dose Radiation

Jerry Cuttler, Ph.D. Nuclear Sciences and Engineering, past president of Canadian Nuclear Society. Ludwig Feinendegen, MD, Professor Emeritus, Heinrich-Heine Universität, Director of the Institute of Medicine at Kernforschungsanlage, Juelich. Yehoshua Socol Ph.D. Experimental High-Energy Physics, Executive Analyst, Falcon Analytics: After the 1956 radiation scare to stop weapons testing, studies focused on cancer induction by low-level radiation. Concern has shifted to protecting “radiation-sensitive individuals.” Since longevity is a measure of health impact, this analysis reexamined data to compare the effect of dose rate on the lifespans of short-lived (5% and 10% mortality) dogs and on the lifespans of dogs at 50% mortality. .. .. If dogs model humans, this evidence would support a change to radiation protection policy. Maintaining exposures “as low as reasonably achievable” (ALARA) appears questionable.

Published in Low Dose Radiation